Some people experience a weight loss plateau on GLP-1 medications
Trials must recruit participants with the target disease characteristics who are representative of that population with respect to comorbidities, concomitant treatments, and other factors
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Stop and seek urgent care for severe allergic reactions, chest pain, trouble breathing, or other emergency warning signs
Hussein MH et al
It is very important for doctors and nurses to keep an eye on patients who are taking GLP-1 receptor agonist drugs for any signs of stomach problems, such as sickness, vomiting, bloating, and feeling full before they should